CLOs on the Move

Cardiovascular Systems, Inc.

www.csi360.com

 
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.csi360.com
  • 1225 Old Highway 8 NW
    Saint Paul, MN USA 55112
  • Phone: 651.259.1600

Executives

Name Title Contact Details

Similar Companies

Summit VetPharm

Summit VetPharm is a Fort Lee, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Ventures Alliance

Healthcare Ventures Alliance is a Erie, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sklar Corporation

Sklar Corporation is a West Chester, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arnold Dental Supply Inc

Arnold Dental Supply Inc is a Lynnwood, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viz

In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.